Merck & Co advanced 4.96% as the best performer on the Dow after the U.S. Food and Drug Administration approved its therapy for adults suffering from a rare lung condition.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Merck & Co advanced 4.96% as the best performer on the Dow after the U.S. Food and Drug Administration approved its therapy for adults suffering from a rare lung condition.
| Subscribe To Our Free Newsletter |
